DefinePK hosts the largest index of Pakistani journals, research articles, news headlines, and videos. It also offers chapter-level book search.
Title: Comparative Study Between Permethrin-5% and Oral Ivermectin for the Treatment of Scabies
Authors: Naheed Khan, Majid Hussain, Bushra Muzaffar, Adeel Siddique, Rizwan Ali Khan, Tamoor Nazir
Journal: Pakistan Armed Forces Medical Journal (PAFMJ)
Publisher: Army Medical College, Rawalpindi.
Country: Pakistan
Year: 2024
Volume: 74
Issue: 3
Language: English
Keywords: IvermectinPermethrinScabies
Objective: To compare the efficacy of 5% Permethrin with the oral Ivermectin for management of scabies.
Study Design: Quasi-experimental Study.
Place and Duration of Study: Department of Dermatology, CMH, Abbottabad Pakistan, from Jun to Nov 2021.
Methodology: Our study enrolled 100 patients, aged 5-80 years, after informed consent. Demographic information and study variables were noted in a data collection tool. All participants were randomly assigned to one of two groups i.e. Group A received Permethrin 5% twice with a one-week interval, whereas Group B received a single dose of oral Ivermectin. The evaluation was conducted at 2-4 week intervals.
Results: From our sample of 100 participants, 57 were females and 43 were males; age ranged from 5 to 80 years. Group A of Permethrin-5% 43(86%) patients’ symptoms improved than in Group B 24(48%) patients of oral Ivermectin. There was also a statistically significant relationship between Permethrin and Ivermectin (p-value<0.001).
Conclusions: Permethrin is more effective than Ivermectin as first dose response. Permethrin is more compliant and safer for scabies patients.
To compare the efficacy of 5% Permethrin with oral Ivermectin for the management of scabies.
Quasi-experimental study involving 100 patients aged 5-80 years. Participants were randomly assigned to two groups: Group A received Permethrin 5% twice with a one-week interval, and Group B received a single dose of oral Ivermectin. Evaluation was conducted at 2-4 week intervals.
graph TD;
A["Enroll 100 Patients"] --> B["Random Assignment"];
B --> C["Group A: Permethrin 5%"];
B --> D["Group B: Oral Ivermectin"];
C --> E["Administer Treatment"];
D --> E;
E --> F["Evaluate at 2-4 Weeks"];
F --> G["Analyze Results"];
G --> H["Compare Efficacy"];
H --> I["Draw Conclusions"];
Permethrin 5% demonstrated better efficacy and compliance as a first-dose treatment for scabies compared to oral Ivermectin. While Permethrin showed faster symptom improvement, oral Ivermectin was noted as useful for severely crusted lesions and immunocompromised patients, often requiring a second dose.
In Group A (Permethrin 5%), 86% of patients showed symptom improvement, compared to 48% in Group B (oral Ivermectin). There was a statistically significant relationship between Permethrin and Ivermectin (p-value < 0.001).
Permethrin is more effective than Ivermectin at first-dose response and offers better compliance and safety for scabies patients.
* The study enrolled 100 patients.
* Permethrin 5% showed symptom improvement in 86% of patients.
* Oral Ivermectin showed symptom improvement in 48% of patients.
Loading PDF...
Loading Statistics...